Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apimeds Pharmaceuticals US, Inc. | Director | Stock Option (right to buy) | 5.78K | May 16, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APUS | Apimeds Pharmaceuticals US, Inc. | May 16, 2025 | 1 | $0 | 4 | May 20, 2025 | Director |
APUS | Apimeds Pharmaceuticals US, Inc. | Mar 4, 2025 | 0 | $0 | 3 | May 8, 2025 | Director |